Gene Name |
major histocompatibility complex, class II, DR beta 1 |
T cell receptor alpha locus |
Image |
|
No pdb structure |
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) ( 23648065)
|
Protein-Protein Interactions |
9 interactors:
CTAG1B
HLA-DMA
HLA-DRA
MAGEA3
MARCH1
TRA
TRB
TRIM21
ZDHHC17
|
15 interactors:
CANX
CD247
CD3D
CD3G
HLA-A
HLA-B
HLA-DRB1
HSPA5
LEF1
NCOA6
SNTA1
TRAT1
TRB
TRD
UBC
|
Entrez ID |
3123 |
6955 |
HPRD ID |
08349 |
01736 |
Ensembl ID |
ENSG00000196126
|
|
Uniprot IDs |
D7RIH8
P01911
P01912
Q29974
Q5Y7D1
|
|
PDB IDs |
1A6A
1BX2
1YMM
2WBJ
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
activates
adenocarcinoma
agonists
analogs
beneficial
cd
du
eliminate
exhibits
far
indiscriminate
inducing
knockout
morphogenesis
natural
possibly
prostate
rar
rars
retinoic
retinoid
retinoids
reverses
rxrs
selective
selectively
synthetic
undermined
undesirable
|
Tagcloud (Difference) ? |
|
activates
adenocarcinoma
agonists
analogs
beneficial
cd
du
eliminate
exhibits
far
indiscriminate
inducing
knockout
morphogenesis
natural
possibly
prostate
rar
rars
retinoic
retinoid
retinoids
reverses
rxrs
selective
selectively
synthetic
undermined
undesirable
|
Tagcloud (Intersection) ? |
|